RESEARCH ASSOCIATE II

Synthesis, purification and characterization of novel chemical compounds. Deliver small to large quantities of by novel chemical entities for drug discovery. Work collaboratively in a team to drive chemistry projects forward. Responsible for safe conduct of reactions. Excellent knowledge in basic and advance organic chemistry. Good knowledge in functional group conversion and multiple step synthesis. Basic knowledge retrosynthetic analysis (desirable). Good expertise in handling pyrophoric reactions. Good knowledge of TLC, column purification, extraction. Excellence in analyzing NMR, IR and Mass Spectrometry data. Always adhere to safe laboratory practices. Enthusiasm to work in a dynamic research environment. Always stretch when project challenge increases. Good knowledge in computer (MS-word/Excel/Power point) and structure drawing (Chem Draw/ISIS) and recording in electronic lab notebook. Good communication and presentation skill. Good in literature search using Reaxys.

Jubilant Bhartia Group is a global conglomerate founded by Mr. Shyam S Bhartia and Mr. Hari S Bhartia with strong presence in diverse sectors like Pharmaceuticals, Contract Research and Development Services, Proprietary Novel Drugs, Life Science Ingredients, Agri Products, Performance Polymers, Food Service (QSR), Food, Auto, Consulting in Aerospace and Oilfield Services. Jubilant Bhartia Group has four flagships Companies- Jubilant Pharmova Limited, Jubilant Ingrevia Limited, Jubilant FoodWorks Limited and Jubilant Industries Limited. Currently the group has a global workforce of around 43,000 employees. Jubilant Biosys Ltd is a part of theJubilant Pharmovafamily of companies with R&D centres in India and business offices in Asia and North America. With our global reach, Jubilant Biosys provides comprehensivedrug discovery servicesand contract research services–from target discovery to candidate selection and with flexible business models (FFS, FTE and risk shared)–in partnership with leading worldwide healthcare companies.